Primary breast lymphoma is a primary degeneration of the breast lymphoid tissue. Study aim to describe primary breast lymphoma; its clinical presentations, histological particularities and management methods. A 33 years-old patient with no medical history underwent a breast surgery. Its anatomo-pathological study, supplemented by immunohistochemistry, showed a primary breast lymphoma. The extension assessment was negative. The patient underwent chemotherapy with regression of the tumor. Breast lymphomas are rare conditions. Its clinical symptomatology is polymorphic and the imaging aspects are non-specific. It should be evoked in front of any breast tumor in order to avoid heavy breast surgery since the basic treatment is based on chemotherapy.
The malignant degeneration of mature ovarian teratomas is a rare phenomenon. Case reported two cases of squamous cell carcinoma developed on mature teratoma of the ovary in patients aged 54 and 41 who were seen for chronic pelvic pain. Their pelvic ultrasound showed cystic double-component images with sizes of 103 and 95 mm respectively suggestive of dermoid cysts, and the anatomopathological study of the pieces of adnexectomy confirmed the diagnosis. Although no clinical, radiological or biological signs are specific, ovarian dermal cyst degeneration is suspected in the presence of a large dermoid cyst in a postmenopausal or peri-menopausal woman. The careful anatomo-pathological study of the cyst in this case makes it possible to pose the diagnosis of certainty. A rare complication of the dermoid cyst, its prognosis is pejorative and depends mainly on its clinical stage at the time of diagnosis and the quality of its surgical treatment which must be as radical as possible.
Background: Breast cancer is a serious disease. Its incidence in young women is constantly increasing. The objective of the study is to analyze the epidemiological, clinical, therapeutic and prognostic characteristics of breast cancer in young women under 35 years-old. Method: This is a retrospective study about 21 cases of patients aged less than 35 years treated in the gynecology and obstetrics department of the university hospital Mohammed VI of Oujda, Morocco between January 2015 and December 2018. Results: The frequency of breast cancer in young women under 35 was 12.7% in our center. The age average was 31.5 years. 38% had a family history of cancer and among them, 28% had a family history of breast cancer, 5% of endometrial cancer and 5% of colon cancer. The self-examination of a nodule was predominant (57.1%). T3 tumors were the most common (43%), followed by T4 tumors (33%). 24% were immediately metastatic with predominantly pulmonary locations (48%). It was invasive carcinoma of nospecial type in 43% of cases, with predominance of SBR grade II and III (84%). Hormone receptors were positive in 57% of cases and no overexpression of HER2 was found. 18 patients underwent surgery, radical in 61% of cases. 18 had a locoregional irradiation, 58.8% received adjuvant chemotherapy. Hormonal therapy was prescribed in 66.6% of cases. After an average follow-up of 14.7 months, 40% presented relapses. The overall 3-years survival was 38% and the relapse-free survival 40%. Conclusion:Our series joins the data of the literature pleading in favor of the more advanced forms and the more unfavorable prognosis of breast cancer in young patients.
Ovarian cystadenofibromas is a benign ovarian tumor that typically affects women in their fifth decade. Its risk factors remain unknown. This case study report 3 cases of ovarian cystadenofibromas treated in our department. The patients are aged 21, 28 and 50 years-old. The clinical pictures were polymorphic but the pelvic ultrasound of the case patients showed cystic ovarian masses suspected of malignancy. Two patients underwent laparoscopic ovarian cystectomy, and the third one, aged 50, underwent laparoscopic adnexectomy. The anatomopathological study showed benign ovarian cystadenofibromas. The operating follow ups were simple. It represents a relatively rare tumor whose macroscopic aspect evokes ovarian cancer wrongly leading to an aggressive surgical attitude.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.